Brendan Kennedy and Anne Gaviola
It’s been an unforgettable year for cannabis, with medicinal use now approved in 35 countries and Canada legalising adult-use in a world first. But behind the headlines and stock prices, there is a company which still has its eyes firmly on the patient health prize. CEO Brendan Kennedy outlines his views on where-to-next for medicinal cannabis; and the legalisation of recreational use.
Wish you were here? Sign up for 2 for 1 discount code for #WebSummit 2019 now: https://news.websummit.com/live-stream